This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2022 Aug;89(8):826.

doi: 10.1007/s12098-022-04237-6. Epub 2022 May 18.

Remdesivir-Induced Liver Injury in a COVID-Positive Newborn

Manjit Kaur¹, Deepika Tiwari¹, Vishal Sidana¹, Kanya Mukhopadhyay²

Affiliations

Affiliations

¹ Advanced Pediatrics Center, Post Graduate Institute of Medical Education & Research, Chandigarh, 160012, India.
² Advanced Pediatrics Center, Post Graduate Institute of Medical Education & Research, Chandigarh, 160012, India. kanyapgi@gmail.com.

PMID: 35583631
PMCID: PMC9116058
DOI: 10.1007/s12098-022-04237-6

Remdesivir-Induced Liver Injury in a COVID-Positive Newborn

Manjit Kaur et al. Indian J Pediatr. 2022 Aug.

. 2022 Aug;89(8):826.

doi: 10.1007/s12098-022-04237-6. Epub 2022 May 18.

Authors

Manjit Kaur¹, Deepika Tiwari¹, Vishal Sidana¹, Kanya Mukhopadhyay²

Affiliations

¹ Advanced Pediatrics Center, Post Graduate Institute of Medical Education & Research, Chandigarh, 160012, India.
² Advanced Pediatrics Center, Post Graduate Institute of Medical Education & Research, Chandigarh, 160012, India. kanyapgi@gmail.com.

PMID: 35583631
PMCID: PMC9116058
DOI: 10.1007/s12098-022-04237-6

No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

Similar articles

Remdesivir for patients with COVID-19.
Wu PE, Morris AM. Wu PE, et al. CMAJ. 2021 Jan 25;193(4):E125. doi: 10.1503/cmaj.202505. Epub 2021 Jan 6. CMAJ. 2021. PMID: 33408097 Free PMC article. No abstract available.
COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2022 Feb 21;64(1644):31-32. Med Lett Drugs Ther. 2022. PMID: 35171898 No abstract available.
Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man.
Day LB, Abdel-Qadir H, Fralick M. Day LB, et al. CMAJ. 2021 Apr 26;193(17):E612-E615. doi: 10.1503/cmaj.210300. CMAJ. 2021. PMID: 33903133 Free PMC article. No abstract available.
Safety profile of the antiviral drug remdesivir: An update.
Fan Q, Zhang B, Ma J, Zhang S. Fan Q, et al. Biomed Pharmacother. 2020 Oct;130:110532. doi: 10.1016/j.biopha.2020.110532. Epub 2020 Jul 22. Biomed Pharmacother. 2020. PMID: 32707440 Free PMC article. Review. No abstract available.
Remdesivir as a broad-spectrum antiviral drug against COVID-19.
Hong YN, Xu J, Sasa GBK, Zhou KX, Ding XF. Hong YN, et al. Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):541-548. doi: 10.26355/eurrev_202101_24426. Eur Rev Med Pharmacol Sci. 2021. PMID: 33506946 Review.

See all similar articles

Cited by

Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management.
Li X, Wang W, Yan S, Zhao W, Xiong H, Bao C, Chen J, Yue Y, Su Y, Zhang C. Li X, et al. Front Pharmacol. 2022 Nov 28;13:1019487. doi: 10.3389/fphar.2022.1019487. eCollection 2022. Front Pharmacol. 2022. PMID: 36518661 Free PMC article. Review.
Extracellular Histones-Friend or Foe?
Tayal A, Sankar J. Tayal A, et al. Indian J Pediatr. 2022 Oct;89(10):966-967. doi: 10.1007/s12098-022-04335-5. Epub 2022 Aug 4. Indian J Pediatr. 2022. PMID: 35925543 No abstract available.
COVID-19 and liver injury: Pathophysiology, risk factors, outcome and management in special populations.
Roshanshad R, Roshanshad A, Fereidooni R, Hosseini-Bensenjan M. Roshanshad R, et al. World J Hepatol. 2023 Apr 27;15(4):441-459. doi: 10.4254/wjh.v15.i4.441. World J Hepatol. 2023. PMID: 37206656 Free PMC article. Review.
Remdesivir: the first FDA-approved anti-COVID-19 Treatment for Young Children.
Chera A, Tanca A. Chera A, et al. Discoveries (Craiova). 2022 Jun 30;10(2):e151. doi: 10.15190/d.2022.10. eCollection 2022 Apr-Jun. Discoveries (Craiova). 2022. PMID: 36156901 Free PMC article. Review.
Drug-Induced Liver Injury in Hospitalized Patients during SARS-CoV-2 Infection.
Karlafti E, Paramythiotis D, Pantazi K, Georgakopoulou VE, Kaiafa G, Papalexis P, Protopapas AA, Ztriva E, Fyntanidou V, Savopoulos C. Karlafti E, et al. Medicina (Kaunas). 2022 Dec 15;58(12):1848. doi: 10.3390/medicina58121848. Medicina (Kaunas). 2022. PMID: 36557050 Free PMC article. Review.

See all "Cited by" articles

References

1. Zampino R, Mele F, Florio LL, et al. Liver injury in remdesivir-treated COVID-19 patients. Hepatol Int. 2020;14:881–883. doi: 10.1007/s12072-020-10077-3. - DOI - PMC - PubMed
1. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 — Final Report. N Engl J Med. 2020;383:1813–1826. doi: 10.1056/NEJMoa2007764. - DOI - PMC - PubMed
1. Adamsick ML, Gandhi RG, Bidell MR, et al. Remdesivir in patients with acute or chronic kidney disease and COVID-19. J Am Soc Nephrol. 2020;31:1384–1386. doi: 10.1681/ASN.2020050589. - DOI - PMC - PubMed
1. Goldman DL, Aldrich ML, Hagmann SHF, et al. Compassionate use of remdesivir in children with severe COVID-19. Pediatrics. 2021 doi: 10.1542/peds.2020-047803. - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources